NEKTAR THERAPEUTICS (NKTR) Stock Balance Sheet
NASDAQ:NKTR • US6402683063
Current stock price
72.22 USD
-2.62 (-3.5%)
At close:
72.218 USD
0 (0%)
After Hours:
| 2025 (2025-12-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 15.12M | 44.25M | 35.28M | 88.20M | 25.20M | |||
| Marketable Securities | 230.64M | 210.97M | 268.34M | 416.80M | 708.70M | |||
| Receivables | 1.78M | 0.00 | 1.21M | 6.00M | 22.50M | |||
| Inventories | N/A | 0.00 | 16.10M | 19.20M | 15.80M | |||
| Other Current Assets | 39.25M | 6.07M | 9.78M | 15.80M | 23.30M | |||
| Total Current Assets | 266.27M | 261.29M | 330.70M | 546.00M | 795.60M | |||
| Non-Current Assets | ||||||||
| PPE Net | 5.00M | 11.82M | 36.86M | 85.90M | 177.50M | |||
| Investments And Advances | 3.49M | 26.09M | 25.82M | 0.00 | 64.80M | |||
| Goodwill | N/A | N/A | 0.00 | 76.50M | 76.50M | |||
| Other Non-Current Assets | 5.65M | 4.65M | 4.64M | 2.20M | 2.70M | |||
| Total Non-Current Assets | 14.14M | 42.56M | 67.33M | 164.60M | 321.60M | |||
| TOTAL ASSETS | 280.41M | 303.85M | 398.03M | 710.60M | 1.12B | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Current Portion Of LT Debt. | N/A | N/A | N/A | N/A | N/A | |||
| Accrued Expenses | 42.77M | 49.84M | 41.42M | 55.20M | 75.50M | |||
| Accounts Payable | 10.77M | 11.56M | 9.85M | 13.00M | 9.70M | |||
| Other Current Liabilities | N/A | N/A | N/A | N/A | N/A | |||
| Total Current Liabilities | 53.54M | 61.40M | 51.27M | 68.20M | 85.20M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 63.16M | 91.78M | 112.63M | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 73.88M | 89.94M | 103.15M | 275.80M | 352.50M | |||
| Total Non-Current Liabilities | 137.04M | 181.71M | 215.78M | 275.80M | 352.50M | |||
| TOTAL LIABILITIES | 190.57M | 243.11M | 267.05M | 344.00M | 437.70M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -3.76B | -3.60B | -3.48B | -3.20B | -2.83B | |||
| Additional Paid In Capital | 3.85B | 3.66B | 3.61B | 3.57B | 3.52B | |||
| Common Shares | 2.00K | 19.00K | 19.00K | 0.00 | 0.00 | |||
| Treasury Stock | 0.00 | -3.00M | N/A | N/A | N/A | |||
| Other Shareholders' Equity | 17.00K | 61.00K | 80.00K | -6.90M | -4.20M | |||
| Shares Outstanding | 20.38M | 12.39M | 12.76M | 12.57M | 12.37M | |||
| Tangible Book Value per Share | 4.41 | 4.90 | 10.27 | 23.08 | 48.77 | |||
| Total Shareholders' Equity | 89.83M | 60.74M | 130.99M | 366.60M | 679.50M | |||
| TOTAL LIABILITIES AND EQUITY | 280.41M | 303.85M | 398.03M | 710.60M | 1.12B | |||
| Statistics | ||||||||
| Debt/Equity | 0.70 | 1.51 | 0.86 | N/A | N/A | |||
| Current Ratio | 4.97 | 4.26 | 6.45 | 8.01 | 9.34 | |||
| Return On Assets (ROA) | -58.51% | -39.15% | -69.36% | -51.82% | -46.89% | |||
| Return On Equity (ROE) | -182.65% | -195.86% | -210.75% | -100.44% | -77.09% | |||
| Return On Invested Capital (ROIC) | N/A | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash (ROICexc) | N/A | N/A | N/A | N/A | N/A | |||
| Return On Invested Capital Ex Cash + Goodwill (ROICexgc) | N/A | N/A | N/A | N/A | N/A | |||
All data in USD , ROIC based on taxRate of 0.21